Relates to capping cost sharing for antiviral COVID-19 therapeutics

Introduced

In Committee

Floor

Crossed Over

Passed

Enacted

Overview Bill text 1 History 1 Sponsors

Requires insurance companies, medical expense indemnity corporations, hospital service corporations, health service corporations and medical assistance programs to provide coverage for prescribed antiviral therapeutics approved by the food and drug administration for the treatment of COVID-19 at no cost to the patient.

Chamber: Senate
Introduced: Mar 27, 2025
Last action: Mar 27, 2025 — REFERRED TO INSURANCE
Session: 2025-2026
Momentum: 26 · Low

PASSAGE PROBABILITY

1% Unlikely

Why this number

Stage base In Committee — base rate 5%, measured from NY's completed sessions
Momentum -5 26/100 from the pace of recorded action
Time since last action -22 564 days quiet

A transparent scoring model over stage, momentum, recency, sponsorship and recorded votes — not a trained predictor. Treat it as a way to rank attention, not as a forecast.